Transforming Prior Authorization to Decision Support.

Area of Science:

• Oncology
• Health Informatics
• Health Economics

Background:

• Prior authorization is a critical process in managing healthcare costs and ensuring appropriate treatment.
• Existing prior authorization systems can be administratively burdensome and may lead to treatment delays.
• The need for efficient and effective prior authorization tools is paramount in cancer care.

Purpose of the Study:

• To evaluate a novel computer-based prior authorization system designed to minimize denials through real-time decision support.
• To assess the system's capability to collect data for a patient registry.
• To determine the impact of the system on chemotherapy costs and guideline adherence.

Main Methods:

• A pilot study was conducted with a large national payer using a new prior authorization tool.
• The tool integrated the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for decision-making.
• Physicians submitted minimal clinical data, receiving immediate authorization for compliant treatment selections.

Main Results:

• During a 1-year pilot, 4,272 cases were reviewed with only 42 denials.
• Chemotherapy drug costs in Florida decreased by 9% compared to the previous year.
• This resulted in an estimated savings of $5.3 million for Florida, while national and regional costs increased.

Conclusions:

• The computer-based prior authorization system effectively minimizes denials and reduces therapy costs.
• The system facilitates compliance with nationally accepted cancer chemotherapy guidelines.
• There is a significant opportunity to lower healthcare expenditures through optimized prior authorization processes.